Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

46.34 -0.79 (-1.67%)
Streaming Delayed Price Updated: 11:03 AM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Collegium Pharmaceutical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Recap: Collegium Pharmaceutical Q4 Earnings ↗
 
Via Benzinga
News headline image
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Analyst Expectations For Collegium Pharmaceutical's Future ↗
 
Via Benzinga
News headline image
Why Collegium Pharmaceutical Shares Are Gaining Today ↗
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced FY24 financial  
Via Benzinga
News headline image
Recap: Collegium Pharmaceutical Q3 Earnings ↗
 
Via Benzinga
News headline image
Needham Maintains Buy Rating for Collegium Pharmaceutical: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Recap: Collegium Pharmaceutical Q1 Earnings ↗
 
Via Benzinga
News headline image
TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a... 
Via Benzinga
Topics Stocks
News headline image
Collegium Provides 2024 Financial Guidance
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Announces $25 Million Accelerated Share Repurchase Program
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Earnings Outlook For Collegium Pharmaceutical ↗
 
Via Benzinga
News headline image
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Reports Third Quarter 2023 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Announces $50 Million Accelerated Share Repurchase Program
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Participate in Jefferies Healthcare Conference
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Reports First Quarter 2023 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Report First Quarter 2023 Financial Results on May 4, 2023
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Publishes Inaugural 2022 Environmental, Social and Governance Report
Highlights 2022 environmental, social and governance achievements 
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.